Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrizio Stocchi

Showing results (151-160 of 254) with videos related to

Pageof 26
Sort By:
Plos One|December 16, 2017
Factors influencing psychological well-being in patients with Parkinson's diseaseAlessandra Nicoletti, Giovanni Mostile, Fabrizio Stocchi, et al.
The Lancet. Neurology|April 13, 2011
A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomesOlivier Rascol, Cheryl J Fitzer-Attas, Robert Hauser, et al.
International Journal of Molecular Sciences|December 2, 2020
Chronic BACE-1 Inhibitor Administration in TASTPM Mice (APP KM670/671NL and PSEN1 M146V Mutation): An EEG StudySusanna Lopez, Claudio Del Percio, Gianluigi Forloni, et al.
Plos One|December 17, 2020
Effect of family history, occupation and diet on the risk of Parkinson disease: A case-control studyMargherita Torti, Chiara Fossati, Miriam Casali, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 20, 2016
A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's diseasePeter A LeWitt, Robert A Hauser, Donald G Grosset, et al.
European Journal of Neurology|February 9, 2023
Gastrointestinal barriers to levodopa transport and absorption in Parkinson's diseaseValentina Leta, Lisa Klingelhoefer, Katherine Longardner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 16, 2013
AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding studyFabrizio Stocchi, Olivier Rascol, Alain Destee, et al.
Frontiers in Psychology|May 14, 2019
Football Players Do Not Show "Neural Efficiency" in Cortical Activity Related to Visuospatial Information Processing During Football Scenes: An EEG Mapping StudyClaudio Del Percio, Mauro Franzetti, Adelaide Josy De Matti, et al.
Journal of Neurology|August 1, 2025
Correction: Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson's disease: pooled analysis of patient level data from two randomized open-label studiesJoaquim J Ferreira, Jee-Young Lee, Hyeo-Il Ma, et al.
Frontiers in Psychology|September 27, 2019
Corrigendum: Football Players Do Not Show "Neural Efficiency" in Cortical Activity Related to Visuospatial Information Processing During Football Scenes: An EEG Mapping StudyClaudio Del Percio, Mauro Franzetti, Adelaide Josy De Matti, et al.
Pageof 26

Showing results (151-160 of 254) with videos related to

Sort By:
Pageof 26
Plos One|December 16, 2017
Factors influencing psychological well-being in patients with Parkinson's diseaseAlessandra Nicoletti, Giovanni Mostile, Fabrizio Stocchi, et al.
The Lancet. Neurology|April 13, 2011
A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomesOlivier Rascol, Cheryl J Fitzer-Attas, Robert Hauser, et al.
International Journal of Molecular Sciences|December 2, 2020
Chronic BACE-1 Inhibitor Administration in TASTPM Mice (APP KM670/671NL and PSEN1 M146V Mutation): An EEG StudySusanna Lopez, Claudio Del Percio, Gianluigi Forloni, et al.
Plos One|December 17, 2020
Effect of family history, occupation and diet on the risk of Parkinson disease: A case-control studyMargherita Torti, Chiara Fossati, Miriam Casali, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 20, 2016
A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's diseasePeter A LeWitt, Robert A Hauser, Donald G Grosset, et al.
European Journal of Neurology|February 9, 2023
Gastrointestinal barriers to levodopa transport and absorption in Parkinson's diseaseValentina Leta, Lisa Klingelhoefer, Katherine Longardner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 16, 2013
AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding studyFabrizio Stocchi, Olivier Rascol, Alain Destee, et al.
Frontiers in Psychology|May 14, 2019
Football Players Do Not Show "Neural Efficiency" in Cortical Activity Related to Visuospatial Information Processing During Football Scenes: An EEG Mapping StudyClaudio Del Percio, Mauro Franzetti, Adelaide Josy De Matti, et al.
Journal of Neurology|August 1, 2025
Correction: Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson's disease: pooled analysis of patient level data from two randomized open-label studiesJoaquim J Ferreira, Jee-Young Lee, Hyeo-Il Ma, et al.
Frontiers in Psychology|September 27, 2019
Corrigendum: Football Players Do Not Show "Neural Efficiency" in Cortical Activity Related to Visuospatial Information Processing During Football Scenes: An EEG Mapping StudyClaudio Del Percio, Mauro Franzetti, Adelaide Josy De Matti, et al.
Pageof 26